Strides Arcolab Limited has got approval from the United States Food & Drug Administration (FDA) for lamivudine and zidovudine tablets USP, 150 mg/300 mg for HIV therapy.
GlaxoSmithKline Pharmaceutical, a leading MNC in India, suffered a setback during the 15 months period ended March 2015 and its consolidated net profit on an annual basis decreased by 20.9 per cent to Rs.381.12 crore from Rs.481.67 crore in the year ended December 2013.
AstraZeneca has entered pact with Abbott to develop companion diagnostic tests who are most likely to benefit from the investigational biological therapy, tralokinumab. Till now no companion diagnostic blood tests have been approved for use in asthma.
[adsense:336x280:8701650588]
PhoreMost Ltd, a biopharmaceutical company has been selected to receive a funding award of £1.4 mn (approximately $2.14 mn USD) from the UK’s innovation agency, Innovate UK, to develop its lead oncology programme targeting mutant KRAS cancers. PhoreMost’s lead therapeutic programme has identified drug candidates to a novel synthetic-lethal target for KRAS.
Biotronik, a leading manufacturer of cardio and endovascular medical devices has completed BIOVALVE first-in-human trial for its new transcatheter aortic valve. Biotronik implanted the device in patients suffering from severe symptomatic aortic stenosis.
Dr. Reddy's Laboratories Limited announced the launch of Somazina®, the innovator brand of Citicoline in the Indian market. Dr. Reddy’s has partnered with the global innovator of Citicoline, Ferrer Internacional S.A., Spain, to make Somazina® available in India. This is an important product in the management of stroke and has been used for the treatment of post-stroke patients around the world.
AbbVie, a research-based biopharmaceutical company, has been granted breakthrough therapy designation to Venetoclax by the US FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.
By introducing mobile drug testing lab, making it the first state in the country to possess such a high tech on the go-spot-detecting drug testing laboratory. The state government invest Rs. 1 crore from the funds allocated to the Gujarat Food and Drug Control Administration (FDCA) for this purpose.
Biocon’s chairman and managing director Kiran Mazumdar-Shaw, got 2nd rank in ‘The Medicine Maker Power List' 2015, an index of the 100 most influential people across the globe in the field of medicine. The top 5 in ‘The Medicine Maker Power List’ are: Anthony Fauci, director, National Institute of Allergy and Infectious Diseases, USA, Kiran Mazumdar-Shaw, chairman & managing director, Biocon, Sir Andrew Witty, chief executive officer, GlaxoSmithKline, Arthur D. Levinson, chief executive officer, Calico and Heather Bresch, chief executive officer of Mylan.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
